SecBot SecBot
SECBOTREPLAY Home › Report › KURA

KURA · Kura Oncology CEO Troy Wilson purchased 100,000 shares worth $1.11M on…

Kura Oncology, Inc. · INSIDER-BUY filed Aug 17, 2026 at 16:45 ET

At the news

BULLISHIMPACT 7/10

INSIDER-BUY filed Aug 17, 2026 at 16:45 ET

Kura Oncology CEO Troy Wilson purchased 100,000 shares worth $1.11M on the open market at $11.12/share, representing a material insider conviction buy. This is a strong standalone bullish signal from the highest-ranking insider, particularly notable given the company's $966M market cap and the CEO's direct cash deployment.

  • CEO Troy Wilson purchased 100,000 shares at $11.12/share for total consideration of $1,112,000
  • Purchase represents approximately 0.12% of KURA's $966M market cap
  • This is the only insider trade in the past 7 days and the only buy in the past 30 days
  • CEO is the highest-ranking insider, making this a conviction buy signal

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access